• +91-9463-70-9464
  • info@medbiosoft.com

Publications

Clinical Database

  • Singh SK, Malik A, Firoz A, Jha V. CDKD: a clinical database of kidney diseases. BMC Nephrol. 2012; 13:23.

  • Singh SK, Reddy SM. Database of nsSNPs for hub genes identified from Plasmodium falciparum RNA-seq data. Indian J Pharmacol 2019; 51:389-99.

  • Firoz A, Malik A, Singh SK, Jha V, Ali A. Database of nsSNPs for hub glycogenes identified from mouse RNA-seq data. Gene. 2015; 574:235-46.

NGS Data Analysis

  • Singh SK, Reddy SM. Investigation of hub genes and their nonsynonymous single nucleotide polymorphism analysis in Plasmodium falciparum for designing therapeutic methodologies using next-generation sequencing approach. Indian J Pharmacol 2019; 51:389-99.

  • Firoz A, Malik A, Singh SK, Jha V, Ali A. Identification of hub glycogenes and their nsSNP analysis from mouse RNA-Seq data. Gene. 2015; 574:235-46.

  • Firoz A, Malik A, Singh SK, Jha V, Ali A. Comparative Analysis of Glycogene Expression in Different Mouse Tissues Using RNA-Seq Data. Int J Genomics. 2014; 2014:837365.

Computer-Aided Drug Designing

  • Singh SK, Reddy SM. Homology modelling, docking, ADMET studies and prediction of deleterious nonsynonymous single nucleotide polymorphisms (nsSNPs) of thiamin phosphate synthase: a potential drug target in Plasmodium falciparum. Indian J Pharm Sci (In press).

  • Singh SK, Reddy SM. Computational prediction of the effects of non-synonymous single nucleotide polymorphisms in the GPI-anchor transamidase of Plasmodium falciparum. Comput Biol Chem (Under revision).

  • Prajapat M, Sarma P, Shekhar N, Kaur H, Singh S, Kumar S, Kaur H, Mahendiratta S, Sharma AR, Kaur S, Mahalmani VM, Medhi B. In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti‐Alzheimer drug therapy. J Adv Pharm Technol Res (In press).

  • Prajapat M, Shekhar N, Sarma P, Avti P, Singh S, Kaur H, Bhattacharyya A, Kumar S, Sharma S, Prakash A, Medhi B. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model 2020.

  • Sarma P, Shekhar N, Prajapat M, Avti P, Kaur H, Kumar S, Singh S, Prakash A, Medhi B. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics. 2020

Book Chapter

  • Singh SK, Malik A, Firoz A, (2014). Chapter 35 COMPUTER AIDED DRUG DISCOVERY (CADD): A QSAR APPROACH. Advanced Pharmacology (pp. 450-475). Hyderabad, Andhra Pradesh, INDIA: PharmaMed Press/BSP Books